Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
25.45
+0.19 (0.75%)
At close: Dec 5, 2025, 4:00 PM EST
25.97
+0.52 (2.04%)
After-hours: Dec 5, 2025, 7:54 PM EST
Arcus Biosciences Employees
Arcus Biosciences had 627 employees as of December 31, 2024. The number of employees increased by 50 or 8.67% compared to the previous year.
Employees
627
Change (1Y)
50
Growth (1Y)
8.67%
Revenue / Employee
$382,775
Profits / Employee
-$543,860
Market Cap
3.15B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RCUS News
- 2 days ago - Arcus Biosciences, Inc. (RCUS) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 17 days ago - Arcus Biosciences to Participate in Two Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Arcus Biosciences President Sells $2 Million in Stock Under Trading Plan - The Motley Fool
- 5 weeks ago - Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock - Business Wire
- 5 weeks ago - Arcus Biosciences Announces Commencement of Public Offering of Common Stock - Business Wire
- 5 weeks ago - Arcus Biosciences Reports Third-Quarter 2025 Financial Results and Provides a Pipeline Update - Business Wire
- 6 weeks ago - Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia - Business Wire
- 7 weeks ago - Arcus Biosciences: Refusing To Let The TIGIT Story Die, And Finding Potential Niches In Huge Markets - Seeking Alpha